Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetylcholine receptor antibody
anorexia
autoantibodies
autoimmune autonomic ganglionopathy
autonomic dysfunction
carcinoma
carcinoma of stomach
cauda equina, enhancement
constipation
cranial nerve enhancement
early satiety
erectile dysfunction
gammaglobulin therapy, intravenous
gastroparesis
hypoglycorrhachia
immunotherapy
libido, decreased
lightheaded
meningeal enhancement
meningitis, carcinomatous
neoplasm, metastatic
norepinephrine
orthostatic hypotension
pupil, abnormality in neurologic disorders
pupil, light reflex of
pupil, light reflex, abnormal
pupil, light reflex, reversed
pure autonomic failure
recurrent
rituximab
sicca syndrome
signet-ring carcinoma
skin, lesions in neurologic disorders
skin, metastasis
syncope
treatment of neurologic disorder
upright-tilt test
urinary retention
visual fields, constricted
weight loss
Showing articles 200 to 250 of 464 << Previous Next >>

Contribution of Susceptibility-Weighted Imaging to Acute Stroke Assessment
Stroke 35:1989-1994, Hermier,M. &Nighoghossian,N., 2004

Role of Magnetic Resonance Imaging Within Diagnostic Criteria for Multiple Sclerosis
Ann Neurol 56:273-278, Miller,D.H.,et al, 2004

Idiopathic Hyposmia As a Preclinical Sign of Parkinson's Disease
Ann Neurol 56:173-181,169, Ponsen,M.M.,et al, 2004

Hyperacute Ischemic Stroke: Middle Cerebral artery Susceptibility Sign at Echo-Planar Gradient-Echo MR Imaging
Radiology 232:466-473, Rovira,A.,et al, 2004

Monoamine Oxide Type B Inhibitors in Early Parkinson's Disease:Meta-Analysis of 17 Randomised Trials Involving 3525 Patients
BMJ 329:593-596, Ives,N.J.,et al, 2004

Higher Risk of Further Vascular Events Among Tran sient Ischemic Attack Patients with Diffusion-Weighted Imaging Acute Ischemic Lesions
Stroke 35:2313-2319, Purroy,F.,et al, 2004

Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004

Long-Term Brain Magnetic Resonance Imaging Changes After Optic Neuritis in Patients Without Clinically Definite Multiple Sclerosis
Arch Neurol 61:1538-1541, Optic Neuritis Study Group, 2004

Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis
Archn Neurol 61:1515-1520, Achiron,A.,et al, 2004

Stroke Wars: Episode IV
AJNR 25:1304-1309, Zimmerman,R.D., 2004

Autonomic Failure as the Initial Presentation of Parkinson Disease and Dementia with Lewy Bodies
Neurol 63:1093-1095, Kaufmann,H.,et al, 2004

Immediate Computed Tomography Scanning of Acute Stroke is Cost-Effective and Improves Quality of Life
Stroke 35:2477-2483, Wardlaw,J.M.,et al, 2004

Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004

Preclinical Alzheimer Disease
Neurol 63:2341-2347, Saxton,J.,et al, 2004

Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke
Stroke 35:147-150, Brown,D.L.,et al, 2004

Treatments of Parkinson Disease
Arch Neurol 60:1680-1684, Shults,C.W., 2003

New Diagnostic Criteria for Multiple Sclerosis
Neurol 60:27-30,6, Tintore,M.,et al, 2003

Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003

Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003

Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003

Reappraisal of Early CT signs to Predict the Arterial Occlusion Site in Acute Embolic Stroke
JNNP 74:649-653, Koga,M.,et al, 2003

New T2 Lesions Enable an Earlier Diagnosis of Multiple Sclerosis in Clinically Isolated Syndromes
Ann Neurol 53:673-676, Dalton,C.M.,et al, 2003

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Sensitivity and Interrater Agreement of CT and Diffusion-Weighted MR Imaging in Hyperacute Stroke
AJNR 24:878-885, Saur,D.,et al, 2003

Validation of Diagnositc Magnetic Resonance Imaging Criteria for Multiple Sclerosis and Response to Interferon B1a
Ann Neurol 53:718-724, Barkhof,F.,et al, 2003

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003

High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis
Arch Ophthalmol 121:944-949, Optic Neuritis Study Group, 2003

Operational Definitions for the NINDS-AIREN Criteria for Vascular Dementia
Stroke 34:1907-1912, van Straaten,E.C.W.,et al, 2003

The Utility of MRI in Suspected MS, Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 61:602-611,596, Frohman,E.M.,et al, 2003

Early Alzheimer's Disease
NEJM 349:1056-1063, Kawas,C.H., 2003

Spinal Cord MRI in Clinically Isolated Optic Neuritis
JNNP 74:1577-1580, Dalton,C.M.,et al, 2003

Validation of Computed Tomographic Middle Cerebral Artery "Dot" Sign
Stroke 34:2636-2640, Leary,M.C.,et al, 2003

Stroke
Lancet 362:1211-1224, Warlow,C.,et al, 2003

Measurement of the Ischemic Penumbra With MRI: It's About Time
Stroke 34:2533-2534, Warach,S., 2003

Identification of New Presenilin Gene Mutations in Early-Onset Familial Alzheimer Disease
Arch Neurol 60:1541-1544,1521, Tedde,A.,et al, 2003

A Longitudinal Study of Abnormalities on MRI and Disability From Multiple Sclerosis
NEJM 346:158-164,199, Brex,P.A.,et al, 2002

Functional Deficits in Patients with Mild Cognitive Impairment
Neurol 58:758-764, Tabert,M.H.,et al, 2002

Changes in Blood Flow and Oxygen Metabolism During Visual Stimulation in Carotid Artery Disease
Stroke 33:1294-1300, Yamauchi,H.,et al, 2002

Interferon Beta-1a for Early Multiple Sclerosis: CHAMPS Trial Subgroup Analyses
Ann Neurol 51:481-490, Beck,R.W.,et al, 2002

Prognostic Accuracy of Cerebral Blood Flow Measurement by Perfusion Computed Tomography, at the Time of Emergency Room Admission, in Acute Stroke Patients
Ann Neurol 51:417-432,415, Wintermark,M.,et al, 2002

Application of the New McDonald Criteria to Patients with Clinically Isolated Syndromes Suggestive of Mulitple Sclerosis
Ann Neurol 52:47-53, Dalton,C.M.,et al, 2002

CT and Conventional and Diffusion-weighted MR Imaging in Acute Stroke: Study in 691 Patients at Presentation to the Emergency Department
Radiology 224:353-360, Mullins,M.E.,et al, 2002

Demonstration of Acute Ischemic Lesions in the Fetal Brain by Diffusion Magnetic Resonance Imaging
Ann Neurol 52:243-246, Baldoli,C.,et al, 2002

Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients
Stroke 33:2025-2031, Wintermark,M.,et al, 2002

Predictors of Hemorrhagic Transformation After Intravenous Recombinant Tissue Plasminogen Activator
Stroke 33:2047-2052, Selim,M.,et al, 2002

Progressive Ventricular Enlargement in Patients with Clinically Isolated Syndromes is Associated with the Early Development of Multiple Sclerosis
JNNP 73:141-147, Dalton,C.M.,et al, 2002

Signs of Acute Stroke Seen on Fluid-Attenuated Inversion Recovery MR Imaging
AJR 179:237-243, Makkat,S.,et al, 2002

Influence of Availabiity of Clinical History on Detection of Early Stroke Using Unenhanced CT and Diffusion-Weighted MR Imaging
AJR 179:223-228, Mullins,M.E.,et al, 2002

Prediction of Early Neurological Deterioration Using Diffusion- and Perfusion-Weighted Imaging in Hyperacute Middle Cerebral Artery Ischemic Stroke
Stroke 33:2197-2205, Arenillas,J.F.,et al, 2002

CT and Diffusion-Weighted MR Imaging in Randomized Order
Stroke 33:2206-2210,2144, Fiebach,J.B.,et al, 2002



Showing articles 200 to 250 of 464 << Previous Next >>